What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feasibility clinical trial

Routine thromboprophylaxis (TP) in newly-diagnosed multiple myeloma (NDMM) patients comprises either aspirin for standard risk patients or low molecular weight heparin for high risk patients. Studies using DOACs in cancer patients include few with myeloma. The aim of this feasibility clinical trial...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thromb Thrombolysis
Main Authors: Sayar, Zara, Czuprynska, Julia, Patel, Jignesh P., Benjamin, Reuben, Roberts, Lara N., Patel, Raj K., Cornelius, Victoria, Arya, Roopen
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6599493/
https://ncbi.nlm.nih.gov/pubmed/31168688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-019-01891-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados